All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0868 | Anti-ERCC5 (8H7) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 8H7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0869 | Anti-ERCC5 (1B5) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1B5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0870 | Anti-ERCC5 (3H55) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 3H55 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0871 | Anti-ERCC5 (8J112) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 8J112 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0872 | Anti-ERCC5 (10F596) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 10F596 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1768 | Anti-ERCC5 (8H7) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 8H7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1769 | Anti-ERCC5 (1B5) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1B5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1770 | Anti-ERCC5 (3H55) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 3H55 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1771 | Anti-ERCC5 (8J112) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 8J112 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1772 | Anti-ERCC5 (10F596) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 10F596 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION